Samuel Trammell will Present his Research December 12, 2013

Sam’s Abstract:

NAD+ METABOLOMICS AND ITS APPLICATION TO NICOTINAMIDE RIBOSIDE THERAPIES IN RODENTS

To support experiments that range from in vitro biochemistry to yeast, vertebrate cell culture, mouse, rat and human trials, we have improved upon our earlier LC-MS/MS assay of the NAD+ metabolome (1). The new assay utilizes separations on porous graphitic carbon and two sets of internal standards to overcome ion suppression effects plaguing external calibration based quantitation methods (2). This presentation will review newly optimized methods for separation and quantification of closely related analytes. Moreover, we will present evidence that the novel NAD+ precursor nicotinamide riboside supplementation prevents diabetic neuropathy in a Type 1 diabetic rat model.

Advertisements

Posted on December 12, 2013, in Student Seminar. Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: